NCT01765413View on ClinicalTrials.gov

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Healthy
Interventions
BIOLOGICAL

Varicella-zoster virus

BIOLOGICAL

Yellow Fever Vaccine

BIOLOGICAL

Placebo

Trial Locations (1)

GU2 7XP

University of Surrey, (Surrey Clinical Research Centre), Guildford

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

Innovative Medicines Initiative

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

lead

University of Surrey

OTHER

NCT01765413 - Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines | Biotech Hunter | Biotech Hunter